Anti-EGFR sheep monoclonal antibody

Drug Profile

Anti-EGFR sheep monoclonal antibody

Alternative Names: Sheep anti-EGFR monoclonal antibody; SMA EGFR

Latest Information Update: 27 Sep 2002

Price : $50

At a glance

  • Originator KS Biomedix Holdings; Oxford Radcliffe Hospitals Trust; Royal Marsden Hospital
  • Class Monoclonal antibodies
  • Mechanism of Action Epidermal growth factor inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Bladder cancer; Breast cancer; Lung cancer; Skin cancer

Most Recent Events

  • 27 Sep 2002 Discontinued - Preclinical for Skin cancer in United Kingdom (unspecified route)
  • 27 Sep 2002 Discontinued - Preclinical for Lung cancer in United Kingdom (unspecified route)
  • 27 Sep 2002 Discontinued - Preclinical for Breast cancer in United Kingdom (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top